Skip to main content
. Author manuscript; available in PMC: 2013 Jul 25.
Published in final edited form as: Pediatr Blood Cancer. 2010 Apr;54(4):552–558. doi: 10.1002/pbc.22327

Fig. 1.

Fig. 1

Panel reactive antibody (PRA) results for class I HLA antibodies in patients with red blood cell (RBC) antibodies (n = 30) and without RBC antibodies (n = 43). PRA ≥3% indicates the presence of HLA antibodies. PRA for class I antibodies was positive in 50% (n = 15) of patients with RBC antibodies and 21% (n = 9) of patients without RBC antibodies (P = 0.0093). High PRA >50% was more common among patients with RBC antibodies.